đ SCREENING
†Universal newborn hearing screen (OAE + ABR) by 1 month.
†High-risk registries (CMV, meningitis, family history).
†Periodic monitoring for delayed-onset SNHL (CMV, genetic).
đ©ș DIAGNOSTIC TESTS
†Diagnostic ABR (threshold estimation).
†Behavioral audiometry (VRA 6-30mo, play 2.5-5yr).
†Tympanometry + acoustic reflexes.
†CT temporal bone (EVA, Mondini).
†Genetic testing (GJB2, SLC26A4, mtDNA).
†CMV PCR (saliva/urine, dried blood spot).
đ ACCURATE TREATMENT
†Conductive: treat OME, surgical repair of ossicles.
†SNHL: hearing aids (by 1 month post-dx).
†Cochlear implant (severe-profound, FDA >9 mo).
†Valganciclovir for congenital CMV with SNHL.
†Genetic counseling.
đ§ MNEMONIC (SNHL workup)"CHARGED" â CMV, Hearing tests, Audiogram, Risk factors, Genetics, EVA on CT, Diagnosis by 3 months.
đčC: CMV screening
đčH: History & High risk
đčA: ABR/Audiometry
đčR: Refer early intervention
đčG: GJB2 / Pendred
đčE: EVA / Imaging